http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20329266
Outgoing Links
Predicate
Object
contentType
Journal Article|Review
issn
0920-1211
pageRange
106340-
publicationName
Epilepsy Research
startingPage
106340
bibliographicCitation
Armeno M, Caraballo R. The evolving indications of KD therapy. Epilepsy Res. 2020 Jul;163():106340. doi: 10.1016/j.eplepsyres.2020.106340. PMID: 32330835.
creator
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6a560ead0144f30c9905c51ecb273409
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5045bfaa89ff42836e0f644ea3f983d
date
202007
identifier
https://doi.org/10.1016/j.eplepsyres.2020.106340
https://pubmed.ncbi.nlm.nih.gov/32330835
isPartOf
https://portal.issn.org/resource/ISSN/0920-1211
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
language
English
source
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title
The evolving indications of KD therapy
discusses
http://id.nlm.nih.gov/mesh/M0001382
hasPrimarySubjectTerm
http://id.nlm.nih.gov/mesh/D000927Q000627
http://id.nlm.nih.gov/mesh/D004827Q000188
http://id.nlm.nih.gov/mesh/D055423Q000009
hasSubjectTerm
http://id.nlm.nih.gov/mesh/D055536
http://id.nlm.nih.gov/mesh/D012640Q000188
http://id.nlm.nih.gov/mesh/D013226Q000188
http://id.nlm.nih.gov/mesh/D013226Q000532
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6608
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7617
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9299
Total number of triples:
30
.